HIAcode Blog

Clinical Validation - Acute Respiratory Failure Secondary to COPD Exacerbation

Written by Juana M. Rodriguez BSN, RN, CPC, CRC, CCDS | Mar 11, 2026 3:18:28 PM

Acute respiratory failure is frequently documented in patients admitted with chronic obstructive pulmonary disease (COPD) exacerbations, but clinical validation requires careful review of objective indicators. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification provides clinical criteria that can help healthcare organizations, CDI specialists, and coding professionals determine when severe COPD exacerbation and respiratory failure are supported by the medical record. Understanding GOLD diagnostic indicators such as hypercapnia, acidosis, oxygen saturation, and respiratory distress can help ensure documentation accuracy and defensible coding. This CDI Tip reviews GOLD criteria, clinical indicators, treatment considerations, and CDI documentation review strategies for validating acute respiratory failure secondary to COPD exacerbation.

Chronic obstructive pulmonary disease (COPD) is a progressive lung disease causing obstructed or restricted airflow resulting in chronic breathing problems. The leading cause of COPD is smoking, other factors include secondhand smoke, genetics, environmental exposure to air pollutants and chemical fumes/dust.

Image courtesy of Wikemedia.org

The two main types of COPD include chronic bronchitis and emphysema.

Image courtesy of Wikemedia.org

  • Chronic bronchitis - Irritants cause inflammation in the lining of the airways, producing slimy mucus, and making it very difficult to breathe.

  • Emphysema – Irritants cause damage of the air sacs, causing them to lose their elasticity and shape so they no longer fill properly with air, making it difficult to exhale.

Image courtesy of live.staticflickr.com

What is The Global Initiative for Chronic Obstructive Lung Disease (GOLD) Classification?

The GOLD classification was initiated by the National Heart, Lung, and Blood Institute (NHLBI) and The World Health Organization (WHO) in 1997 to assess, diagnose, and guide treatment for COPD. Treatment may require oxygen therapy, nebulizer bronchodilator therapy, or corticosteroids.

Diagnosing COPD

Under the GOLD classification COPD is diagnosed based on symptoms and spirometry.

  • Symptoms: dyspnea, coughing, wheezing, chest tightness, excess mucus production, and increased tiredness.
  • Spirometry: a noninvasive test that is important for the staging of severity of COPD as mild, moderate, severe, and very severe. Spirometry measures forced vital capacity (FVC) and forced expiratory volume (FEV-1).
    • Forced Vital Capacity (FVC) - breathing out the most air after a deep breath.
    • Forced Expiratory Volume (FEV-1) - how much air you can exhale in 1 second.

COPD Exacerbation

COPD exacerbation (ECOPD) is characterized by worsening respiratory symptoms lasting up to 2 weeks. Increased tiredness, breathlessness, frequent coughing spells, and change in color/consistency of mucus production. Sometimes leading to acute respiratory failure needing prompt medical attention and including changes in daily maintenance treatment or visit to the emergency department.

Clinically Validating Acute Respiratory Failure due to COPD exacerbation Using the GOLD Classification Definition

The GOLD classification serves as a guide providing clinical criteria to identify both ECOPD and acute respiratory failure secondary to ECOPD.

The clinical criteria for Severe ECOPD include:

Evidence of worsening hypercapnia and acidosis can be measured via Arterial Blood Gas (ABG) PaCO2 > 45 and pH < 7.35 OR Venous Blood Gas (VBG) pCO2 > 50 and pH < 7.33 AND ≥ 3 of the following:

  • Dyspnea, shortness of breath
  • RR > 24
  • HR > 95
  • Resting SPO2 <92 [PaO2 ≤ 60] on room air and/or change >3% (when known)
  • Resting SPO2 <92 [PaO2 ≤ 60] on usual oxygen prescription
  • C-reactive protein (CRP) ≥ 10

Severe ECOPD with Acute or Acute on Chronic Respiratory Failure

Severe ECOPD with acute or acute on chronic respiratory failure is evidenced by meeting the Severe ECOPD diagnostic criteria mentioned above and 1 of the following:

  • RR > 24
  • Accessory Muscle use (suprasternal or intercostal retractions, labored breathing, paradoxical breathing)
  • Hypoxemia improved with supplemental Oxygen >35% [or need BIPAP, CPAP, Mechanical Ventilation]
  • Hypercapnia: PaCO2 ≥ 50 (or PvCO2 > 55) or increased compared with baseline

Documentation

A thorough analysis of medical records for acute respiratory failure secondary to ECOPD include reviewing practitioner and ancillary staff notes (nursing, physical therapy and respiratory therapy) for confirmation of abnormal breathing patterns. These notes show daily documentation of dyspnea, dyspnea on exertion, accessory muscle use, and oxygen saturation using pulse oximetry. Pulse oximetry readings can also be found in the vital signs log along with heart rate and respirations. The levels of oxygen and carbon dioxide in the blood are measured through ABGs and/or VBGs. Measurements are found in the results review tab under blood gases. These provide clinical indicators that can be used to prove diagnoses are clinically supported.

Treatment for ECOPD and Acute or Acute on Chronic Respiratory Failure

Treatment for ECOPD and acute respiratory failure may include addressing the underlying cause of the exacerbation to reverse the airway obstruction. Treatment may be antibiotics, inhaled bronchodilators via nebulizer treatment (Albuterol, Levalbuterol), and/or systemic corticosteroids (Prednisone, Prednisolone, Methylprednisolone, Dexamethasone). Stabilizing the patient with oxygen therapy via nasal canula may suffice, may not need high flow oxygen.

Important To Note

The GOLD classification diagnostic criteria is a guide to diagnose acute respiratory failure secondary to ECOPD, it does not apply for Acute Hypoxemic Respiratory Failure without Hypercapnia. If the patient’s clinical indicators do not meet the GOLD classification definition for acute respiratory failure and/or COPD exacerbation, be aware this does not mean the patient does not have the condition. CDI will query the provider to clarify incomplete or missing documentation. Per ICD-10-CM Official Guidelines for Coding and Reporting FY 2026, “The assignment of a diagnosis code is based on the provider’s diagnostic statement that the condition exists.”

Scenarios

The following case studies illustrate clinical validation of acute respiratory failure secondary to COPD exacerbation using the GOLD Classification definition, from a CDI Perspective.

SCENARIO 1

H&P: 76-year-old female with history of recurrent COPD exacerbations, HTN, and DM presented with worsening shortness of breath with moderate wheezing. Admitted with COPD exacerbation and respiratory failure. Home oxygen baseline is 2L via nasal canula.

DS: Hypertension, DM, Acute on chronic hypoxic/hypercapnic respiratory failure due to COPD exacerbation. On admission SpO2 of 86% on 2L NC, one time dose of Dexamethasone given and increased oxygen to 4 L per NC, SpO2 increased to 92%, patient discharged in stable condition.

Clinical Indicators: sob, wheezing

Vital Signs: Temp 98.6, HR 101, RR 26, BP 110/65, SpO2 of 86% on 2L NC ABG: pH 7.29, pCO2 59, and HCO3 36

Treatment: Oxygen 4L via NC, Albuterol Neb treatment, Dexamethasone

Can CDI code the diagnoses of ECOPD and acute respiratory failure using the GOLD Classification definition?

YES! This scenario meets the GOLD criteria for ECOPD and acute on chronic hypoxic/hypercapnic respiratory failure.

  • Meets Severe ECOPD: ABG: pH 7.29, pCO2 64 -Meets acidosis and hypercapnia AND meets ≥ 3 criteria needed - RR 26, HR 101, PaO2 59 on 2L NC

  • Meets acute respiratory failure 1 indicator needed– RR 26

 

SCENARIO 2

H&P: 68-year-old male with history of lung cancer, COPD, pulmonary embolism, and chronic diastolic CHF presented with chest discomfort, labored breathing, and increased dyspnea. SPO2 78% on room air, no history of home oxygen. Patient placed on Oxygen 5L via NC. Consult case management for possible home oxygen set up. Admission for respiratory failure secondary to COPD.

DS: Acute hypoxic respiratory failure secondary to COPD, chronic diastolic CHF. CXR revealed left lower lobe consolidation therefore antibiotics were given for possible Pneumonia. Oxygen was weaned off, patient did not meet criteria for home oxygen. Patient treated with antibiotics and oral diuretics. Patient discharged in stable condition.

Clinical Indicators: chest discomfort, labored breathing, dyspnea Vital Signs: Temp 98.4, HR 92, RR 23, BP 115/68, SpO2 of 78% on room air CXR: left lower lobe consolidation

Treatment: Oxygen 5L via NC, IV Rocephin, oral Furosemide.

Can CDI code the diagnoses of COPD and acute hypoxemia respiratory failure using the GOLD Classification guidelines?

NO! This scenario does not meet criteria using the GOLD classification definition for ECOPD and acute respiratory failure.

  • Does not meet ECOPD: The term exacerbation is not included in the diagnoses of COPD.

  • Does not meet ECOPD: no ABG were performed to provide evidence of acidosis and hypercapnia.

  • Meets acute hypoxic respiratory failure: SpO2 of 78% on room air treated with 40% oxygen therapy via nasal canula. If Gold classification does not apply, CDI will query the provider for clarification of hypoxemia, possibly caused by another condition such as heart failure exacerbation, Pneumonia, or Pulmonary Embolism.

 

Conclusion

The GOLD classification serves as a guide in identifying acute respiratory failure in patients with COPD admitted due to an exacerbation of COPD. Review the clinical definition and diagnostic criteria for severe ECOPD with acute or acute on chronic respiratory failure.

It is important to know the GOLD classification guideline does not apply in patients:

  • Without COPD
  • COPD not in exacerbation
  • Admitted with an acute condition causing acute respiratory failure and contributing to COPD exacerbation.

When the GOLD classification guideline does not meet or does not apply, CDI should query the Provider to clarify inconsistent, conflicting, or vague documentation.

References

FAQ

For the past 30 years, HIA has been the leading provider of compliance audits, coding support services and clinical documentation audit services for hospitals, ambulatory surgery centers, physician groups and other healthcare entities. HIA offers PRN support as well as total outsource support.

The information contained in this coding advice is valid at the time of posting. Viewers are encouraged to research subsequent official guidance in the areas associated with the topic as they can change rapidly.